Role of Wearable Technology and Fitness Apps in Obesity and Diabetes

Author(s):  
Shariq I. Sherwani ◽  
Benjamin R. Bates

Rapid economic growth, industrialization, mechanization, sedentary lifestyle, high calorie diets, and processed foods have led to increased incidence of obesity in the United States of America. Prominently affected by the obesity epidemic are the most vulnerable such as the rural poor and those who have less access to nutritious and healthy foods due to barriers such as socioeconomic, infrastructural, and organizational. Wearable technology (WT) and health fitness applications (apps) have the potential to address some of the health disparities associated with obesity. Monitoring health parameters through WT and Apps using remote sensing technology generates personal health data which can be captured, analyzed, and shared with healthcare providers and others in social support network. Because captured data include protected health information, and breaches can occur, the concerns about health data privacy, personal ownership, and portability are addressed in this chapter.

2018 ◽  
pp. 1068-1083
Author(s):  
Don Kerr ◽  
Kerryn Butler-Henderson ◽  
Tony Sahama

When considering the use of mobile or wearable health technologies to collect health data, a majority of users state security and privacy of their data is a primary concern. With users being connected 24/7, there is a higher risk today of data theft or the misappropriate use of health data. Furthermore, data ownership is often a misunderstood topic in wearable technology, with many users unaware who owns the data collected by a device, what that data can be used for and who can receive that data. Many countries are reviewing privacy governance in an attempt to clarify data privacy and ownership. But is it too late? This chapter explores the concepts of security and privacy of data from mobile and wearable technology, with specific examples, and the implications for the future.


2020 ◽  
Vol 27 (12) ◽  
pp. 1987-1998
Author(s):  
Riley Taitingfong ◽  
Cinnamon S Bloss ◽  
Cynthia Triplett ◽  
Julie Cakici ◽  
Nanibaa’ Garrison ◽  
...  

Abstract Background Privacy-related concerns can prevent equitable participation in health research by US Indigenous communities. However, studies focused on these communities' views regarding health data privacy, including systematic reviews, are lacking. Methods We conducted a systematic literature review analyzing empirical, US-based studies involving American Indian/Alaska Native (AI/AN) and Native Hawaiian or other Pacific Islander (NHPI) perspectives on health data privacy, which we define as the practice of maintaining the security and confidentiality of an individual’s personal health records and/or biological samples (including data derived from biological specimens, such as personal genetic information), as well as the secure and approved use of those data. Results Twenty-one studies involving 3234 AI/AN and NHPI participants were eligible for review. The results of this review suggest that concerns about the privacy of health data are both prevalent and complex in AI/AN and NHPI communities. Many respondents raised concerns about the potential for misuse of their health data, including discrimination or stigma, confidentiality breaches, and undesirable or unknown uses of biological specimens. Conclusions Participants cited a variety of individual and community-level concerns about the privacy of their health data, and indicated that these deter their willingness to participate in health research. Future investigations should explore in more depth which health data privacy concerns are most salient to specific AI/AN and NHPI communities, and identify the practices that will make the collection and use of health data more trustworthy and transparent for participants.


Author(s):  
Don Kerr ◽  
Kerryn Butler-Henderson ◽  
Tony Sahama

When considering the use of mobile or wearable health technologies to collect health data, a majority of users state security and privacy of their data is a primary concern. With users being connected 24/7, there is a higher risk today of data theft or the misappropriate use of health data. Furthermore, data ownership is often a misunderstood topic in wearable technology, with many users unaware who owns the data collected by a device, what that data can be used for and who can receive that data. Many countries are reviewing privacy governance in an attempt to clarify data privacy and ownership. But is it too late? This chapter explores the concepts of security and privacy of data from mobile and wearable technology, with specific examples, and the implications for the future.


2019 ◽  
pp. 1629-1644 ◽  
Author(s):  
Don Kerr ◽  
Kerryn Butler-Henderson ◽  
Tony Sahama

When considering the use of mobile or wearable health technologies to collect health data, a majority of users state security and privacy of their data is a primary concern. With users being connected 24/7, there is a higher risk today of data theft or the misappropriate use of health data. Furthermore, data ownership is often a misunderstood topic in wearable technology, with many users unaware who owns the data collected by a device, what that data can be used for and who can receive that data. Many countries are reviewing privacy governance in an attempt to clarify data privacy and ownership. But is it too late? This chapter explores the concepts of security and privacy of data from mobile and wearable technology, with specific examples, and the implications for the future.


2015 ◽  
Vol 24 (3) ◽  
pp. 256-271 ◽  
Author(s):  
BONNIE KAPLAN

Abstract:Two court cases that involve selling prescription data for pharmaceutical marketing affect biomedical informatics, patient and clinician privacy, and regulation. Sorrell v. IMS Health Inc. et al. in the United States and R v. Department of Health, Ex Parte Source Informatics Ltd. in the United Kingdom concern privacy and health data protection, data de-identification and reidentification, drug detailing (marketing), commercial benefit from the required disclosure of personal information, clinician privacy and the duty of confidentiality, beneficial and unsavory uses of health data, regulating health technologies, and considering data as speech. Individuals should, at the very least, be aware of how data about them are collected and used. Taking account of how those data are used is needed so societal norms and law evolve ethically as new technologies affect health data privacy and protection.


1999 ◽  
Vol 15 (2) ◽  
pp. 316-331 ◽  
Author(s):  
Phyllis Freeman ◽  
Anthony Robbins

After 25 years of debate about privacy of automated personal health data, the U.S. Congress has set a deadline of August 1999 for enacting health information privacy legislation. The urgency to establish national policy in the United States re-emerges with implementation of a 1996 law mandating a unique identifier for each participant in the U.S. medical care system and the use of a uniform electronic data set for all health information transmitted in financial and administrative transactions. The impact of electronic data storage and transmittal on privacy, health outcomes, and medical care is unclear. A three-step analytic scheme can clarify the issues in the policy debate and for future assessment. The first step is intended to elicit, for the first time, a precise, accurate, and reproducible description of personal health data transactions and chains of transactions, independent of the policy preferences of any interested party. The second step allows the reader to analyze these transactions according to who benefits first and foremost from each. This scrutiny clarifies the reasons why parties to the debate tend to disagree. The third step characterizes how Congress is likely to perceive the policy process and consider its options before enacting any particular set of compromises. Understanding the policy deliberations and potential effects of evolving information technologies and new national privacy rules should aid assessment of results.


Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1579-P
Author(s):  
JANNIE NIELSEN ◽  
ED GREGG ◽  
K.M. VENKAT NARAYAN ◽  
SOLVEIG A. CUNNINGHAM

2008 ◽  
Vol 6 (1) ◽  
pp. 31-42 ◽  
Author(s):  
Robyn Matloff ◽  
Angela Lee ◽  
Roland Tang ◽  
Doug Brugge

Despite nearly 12 million Asian Americans living in the United States and continued immigration, this increasingly substantial subpopulation has consistently been left out of national obesity studies. When included in national studies, Chinese-American children have been grouped together with other Asian Americans, Pacific Islanders or simply as “other,” yielding significantly lower rates of overweight and obesity compared to non-Asians. There is a failure to recognize the ethnic diversity of Asian Americans as well as the effect of acculturation. Results from smaller studies of Chinese American youth suggest that they are adopting lifestyles less Chinese and more Americans and that their share of disease burden is growing. We screened 142 children from the waiting room of a community health center that serves primarily recent Chinese immigrants for height, weight and demographic profile. Body Mass Index was calculated and evaluated using CDC growth charts. Overall, 30.1 percent of children were above the 85th we found being male and being born in the U .S. to be statistically significant for BMI > 85th percentile (p=0.039, p=0.001, respectively). Our results suggest that being overweight in this Chinese American immigrant population is associated with being born in the U.S. A change in public policy and framework for research are required to accurately assess the extent of overweight and obesity in Chinese American children. In particular, large scale data should be stratified by age, sex, birthplace and measure of acculturation to identify those at risk and construct tailored interventions.


2020 ◽  
Author(s):  
Shabbir Syed-Abdul ◽  
Shwetambara Malwade ◽  
Sim-Mei Choo

UNSTRUCTURED The outbreak of COVID-19 that started in December 2019, was declared a pandemic in March 2020. Currently, there is no specific treatment recommended and healthcare providers are struggling to find appropriate treatment regimes. Medication misinformation spread through social media has caused panic situations and self-prescription leading to harmful drug effects. The situation worsened following false propaganda via social media, leading to shortage of some medications. Our study shows the frequency of search for the medications Hydroxychloroquine (HCQ), Azithromycin and Bacillus Calmette-Guérin (BCG) vaccine in Google Trends, across 6 countries. Public interests from the United States, Italy and Spain leaned towards HCQ, whereas those from Taiwan, Japan and South Korea were keen towards learning about the BCG vaccine. Our article aimed to inform the general public of the adverse drug reactions to avoid self-prescription or yield to the assumptions of leaders and unanimous social media posts. Proactive participation and preventive measures such as social distancing, use of face masks and hand sanitizers are recommended to help curb COVID-19 and other infections.


Sign in / Sign up

Export Citation Format

Share Document